ResApp‘s smartphone app, called ResAppDx, diagnoses a wide range of respiratory illnesses accurately by using cough sounds, the company reported. The app is successful in diagnosing both chronic obstructive pulmonary disease (COPD) and aggravations of COPD caused by infections, pneumonia, and acute asthma. ResApp’s technology detects cough sounds…
AstraZeneca’s Bevespi Aerosphere was shown to improve lung function in patients with moderate- to very severe-chronic obstructive pulmonary disease (COPD), in the latest PINNACLE 4 clinical trial. The promising results pave the way for regulatory approval in Europe and Asia. Bevespi Aerosphere combines two bronchodilators, glycopyrronium (long-acting…
Synairgen is moving from the treatment of respiratory viral infections in patients with asthma to those with chronic obstructive pulmonary disease (COPD) with its inhaled interferon beta investigative therapy SNG001. The pharmaceutical company is planning a two-part trial of SNG001 to treat viral infections in COPD patients to take place this…
Blue Cross and Blue Shield of Texas (BCBSTX) is investing $10 million to raise awareness for the prevention and early detection of two diseases greatly affecting the health of Texans — chronic obstructive pulmonary disease (COPD) and chronic diabetic kidney disease (CKD) — through its Healthy Kids, Healthy Families grants…
People with chronic obstructive pulmonary disease and bronchiectasis (BE) have more bacterial lung infections, and infections that last longer, than COPD patients without bronchiectasis, a study indicates. Thee findings may explain why BE aggravates COPD, the researchers said. The study, “Exacerbations in COPD Patients with Bronchiectasis,” was…
Get regular updates to your inbox.